Furthermore, no correlation was noted between five SEREX antigens and the three tumor markers (CEA, CA19‐9, and anti‐p53 Abs), indicating that anti‐FIRΔexon2 Abs are an independent candidate marker for patients with CRC. The gene discussed is TP53; the disease is colorectal carcinoma.